Emory Global Diabetes Research Center

Of the Woodruff Health Sciences Center and Emory University


  • Diabetes Phenotypes: where are we and where do we go from here?

    September 6, 2022

    Webinar recording
    Event flyer

    Univ. Prof. Dr. DDr h.c. Michael Roden, M.A. E.
    CEO of the DDZ (German Diabetes Center) in Düsseldorf

    In this webinar, Dr. Roden discussed evidence from recent studies addressing the complexity of diabetes by proposing novel subgroups (subtypes) of diabetes. Several methodological and practical issues need further study: the statistical approach used to define subgroups and derive recommendations for diabetes care; the stability of subgroups over time; the optimal dataset (e.g. phenotypic vs genotypic) for reclassification; the transethnic generalisability of findings; and the applicability in clinical routine care.

  • Diabetes in the Lean in India: What Does it Mean?

    August 30, 2022

    Webinar recording
    Event flyer

    Prof. Nihal Thomas, Mbbs, MD, PhD
    Department of Epidemiology, Christian Medical College, Vellore

    In this webinar, Dr. Thomas presented his research group's ground-breaking work over the past 15 years on why Indians develop Type 2 Diabaetes at a significantly lower body mass index when compared to their Western counterparts. More specifically, they have investigated: the pathogenesis and aetiology of diabetes in the young in India; epidemiological and GWAS studies in the 50-year-old Vellore birth cohort; basic science research involving individuals with low birth weight, enabled by hyperinsulinemic euglycaemic clamp studies; indirect calorimetry and NMR spectrometry; and next generation sequencing techniques to characterize the patterns of beta cell secretion and insulin resistance defects which are different in Indian and Western populations.

  • Diabetes in the US: Good News, Bad News, and Opportunities to Advance Equity

    In this webinar, hosted by the Design and Evaluation for Equity Core of the Georgia Center for Diabetes Translation Research, Core Directors Drs. Mohammed K. Ali and Rachel E. Patzer provided an overview of trends in diabetes prevalence, morbidity, and mortality as well as trends in efforts to address diabetes such as utilization of preventive services and treatments and demonstrate how national and state data can be used to explore and highlight key inequities, particularly in ER and inpatient health service use. They showcased ongoing approaches to address health inequities at various levels through implementation science and described the resources and opportunities available at the GCDTR, specifically data and expertise, relevant to both the design and evaluation of diabetes research studies.

    To view this EGDRC and Georgia Center for Diabetes Translation Research webinar recorded April 14, click here.

  • Precision Medicine for Obesity

    Dr. Andres Acosta's research focuses on gastrointestinal physiology to understand the complexity of food intake regulation and obesity. Dr. Acosta is using cutting-edge techniques to develop a unique and novel approach to “personalized obesity management” based on combination of physiology, genetics and metabolic markers.

    To view this EGDRC and Georgia Center for Diabetes Translation Research webinar recorded April 14, click here.

  • Data, Social Determinants of Health, and Personalized Medicine at the Macro Level

    The guiding principle of Dr. Juan Espinoza’s work over the past decade has been that data and technology have the potential to narrow the health gap faced by underserved communities all over the world. This webinar was hosted by the Technologies Advancing Translation and Equity Core of the Georgia Center for Diabetes Translation Research on March 21, 2022.

    To view the webinar recording, click here.

  • The Pandemic of Diabetes: 100 Years After the Discovery of Insulin Symposium

    One hundred years after the discovery of insulin, diabetes rages as a slow and silent killer, already affecting a half a billion people and growing. This symposium was organized in conjunction with the release of a special issue of Endocrinology and Metabolism Clinics of North America, published in collaboration with Elsevier. Topics included genomics, epidemiology, prevention, quality of care, advances in therapeutics, diabetes in special populations, and precision medicine. For more details and agenda click here.

    To view the symposium recording, click here.

Positions Available

  • Faculty Positions in Artificial Intelligence and Diabetes and Cardiometabolic Diseases

    Woodruff Health Sciences Center, Emory University, is seeking to recruit multiple, open-rank tenure-track faculty (assistant, associate, or full professor) with expertise in Artificial Intelligence (AI) and either experience or interest in its application to diabetes and its complications. Emory is making a major commitment to Artificial Intelligence (AI) with the goal of creating a vibrant and coherent research and teaching community that represents the diverse interests of Emory’s schools and units and expand offerings to undergraduate, graduate, and professional school students.

    To apply, click here or go to https://faculty-emory.icims.com/jobs and search for “91656”. For additional information contact Mark Hutcheson, mhutch3@emory.edu.


  • Woodruff Health Sciences Center establishes Emory Global Diabetes Research Center

    The Woodruff Health Sciences Center and Emory University are building upon the fundamental and critical research and work conducted by the Global Diabetes Research Center at the Rollins School of Public Health and across the campus to establish the Emory Global Diabetes Research Center (EGDRC) of the Woodruff Health Sciences Center at Emory University. Under the continued leadership of executive director K.M. Venkat Narayan, MD, and co-director Mohammed K. Ali, MD, the center will broaden and grow its work to lessen the burden of diabetes and related non-communicable diseases domestically and globally through research, education and outreach.

    The EGDRC will expand its multi-pronged approach to address the problem of diabetes and its associated complications through integrating innovative investigations into the causes and cures for the disease. This includes groundbreaking techniques to explore the root causes of the disease as well as precise ways to personalize medicine for diabetes, interventions to prevent the disease, applications of advanced technologies including artificial intelligence (AI) to improve care delivery, and public health and policy approaches for improving the quality of care and health equity. 

    Click here for full press release.